Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.

about

Lipid Target in Very High-Risk Cardiovascular Patients: Lesson from PCSK9 Monoclonal Antibodies.

Item

http://www.wikidata.org/entity/Q51737068

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@en

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@nl

type

Item

label

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@en

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@nl

prefLabel

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@en

Lipid Target in Very High-Risk ...... m PCSK9 Monoclonal Antibodies.

@nl

P1476

Lipid Target in Very High-Risk ...... om PCSK9 Monoclonal Antibodies

@en

P2093

Giovanni Ciccarelli

http://www.w3.org/2001/XMLSchema#string

Michele De Paulis

http://www.w3.org/2001/XMLSchema#string

Saverio D'Elia

http://www.w3.org/2001/XMLSchema#string

P2860

Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"

Hypertension, serum lipids and cancer risk: A review of epidemiological evidence

Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I

Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia

Mechanism of action of fibrates on lipid and lipoprotein metabolism

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans

P31

scholarly article

P356

10.3390/DISEASES6010022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giovanni Cimmino

Paolo Golino

P577

2018-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29562587

http://www.w3.org/2001/XMLSchema#string

P932

5871968

http://www.w3.org/2001/XMLSchema#string